Literature DB >> 17827907

A case of gastric cancer detected incidentally following to chylothorax, followed by change in the appearance of pleural effusion with cancer progression.

Shinichi Miyazaki1, Hiroyuki Noda, Terumi Morita, Megumi Joman, Mutsuhiro Okada, Yasuo Moriyama, Kazunori Suzuki, Tsutomu Takeuchi.   

Abstract

We report a case of gastric cancer that was detected due to chylothorax. A 64-year-old man visited our hospital with chief complaints of anterior chest pain and right lower leg swelling. Chest X-ray showed bilateral pleural effusion. Biochemical tests of the pleural fluid detected chyle and cytological examination of the left pleural revealed poorly differentiated adenocarcinoma cells. An upper gastrointestinal examination revealed a type 4 gastric cancer that was diagnosed as the primary lesion. The appearance of the pleural effusion changed from chylaus to light yellow as the cancer progressed. Gastric cancer combined with chylothorax is quite rare and we discussed in this report how this change of the appearance of the pleural effusion occurred in comparison with the mechanism of chylothorax.

Entities:  

Mesh:

Year:  2007        PMID: 17827907

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  3 in total

1.  Chylothorax and lymphedema as the initial manifestations of gastric carcinoma: A case report and review of the literature.

Authors:  Jie Wu; Liang Lv; Kunyan Zhou; Jirong Huo
Journal:  Oncol Lett       Date:  2016-02-29       Impact factor: 2.967

2.  Chylothorax in gastric adenocarcinoma: A case report and systematic review of the English literature.

Authors:  Uma Devaraj; Priya Ramachandran; Marjorie Correa; George A D'souza
Journal:  Lung India       Date:  2014-01

Review 3.  Refractory Chylothorax and Lymphedema Caused by Advanced Gastric Cancer.

Authors:  Naoko Nagano; Manabu Suzuki; Kentaro Tamura; Sakurako Kobayashi; Yasushi Kojima; Go Naka; Motoyasu Iikura; Shinyu Izumi; Yuichiro Takeda; Haruhito Sugiyama
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.